Hui Zeng

Nov 25, 2024 | mdpi.com | Hua-Zhi Qin |Yi Wang |Wen-Fei Lin |Hui Zeng

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Aug 12, 2024 | mdpi.com | Hui Zeng |Chao Ma |Meng Wu

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Jun 15, 2024 | onlinelibrary.wiley.com | Hui Zeng |Jie He |Hai-Bo Dong |Min Zhou

1 INTRODUCTION Acute promyelocytic leukemia (APL) represents a medical emergency due to a distinct coagulopathy, prompt diagnosis, and urgent treatment are critical. In addition to morphology, chromosome and fusion gene evaluation, immunophenotypic analysis by flow cytometry has become the standard diagnostic approach due to its effectiveness and rapid results for APL.